Hilltop Holdings (HTH) Jumps on Positive Earnings Call

Jacob Harper |

The parent company of PlainsCapital Corporation Hilltop Holdings (HTH) announced third quarter earnings before the bell on Nov. 12, and the company showed profits that exceeded expectations.

Though revenues came in below expectations, the Dallas-based Hilltop was able to increase profits by cutting costs significantly. Expenses came in at $44 million less than the previous quarter, with employee benefits and compensation decreasing 10.2 percent, or $13.5 million.

In the earnings report, Hilltop CEO Jeremy Ford downplayed any worry about decreasing revenues, attributing them to macro factors out of their control, while highlighting the leaner company profile. Ford also touted the holding company’s third quarter earnings as being indicative of Hiltop’s rosy future, and said earnings “illustrate the diversity of our businesses and their collective profitability.”

For their third quarter 2013 earnings report, Hilltop reported a net gain of $31.8 million, or $0.36 per share, versus the net loss of $4.0 million, or $0.07 per share, from the same period a year ago. Revenue for the quarter was $277.8 million, as compared to $42.8 million from the previous year. Analysts were expecting a net gain of $0.32 per share on revenues of $287 million.

Hilltop rose 8.4 percent on the earnings report to hit $18.72 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
HTH Hilltop Holdings Inc. 24.51 0.38 1.57 217,505
PRSEF Prosafe Se (Cyprus) 0.03 0.00 0.00 0


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…